Success Begins Here

EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs EQRxNews Page

EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

Arboretum_JDOctober 20, 2021

The Essential Role Jan Garfinkle has Played in the Medtech Ecosystem ArboretumNews Page

The Essential Role Jan Garfinkle has Played in the Medtech Ecosystem

Jan joins Andrew Cleeland, CEO of Fogarty Innovation and shares insights behind her successful career.…

Arboretum_JDOctober 20, 2021

SonarMD Sees Exceptional Engagement after Launch in New Market and Announces New CEO Home PageNews PageSonarMD

SonarMD Sees Exceptional Engagement after Launch in New Market and Announces New CEO

SonarMD continues to gain momentum in 2021 as the leading valuebased care coordination solution for…

Arboretum_JDOctober 14, 2021

Turning Point Therapeutics and EQRx Announce Clinical Collaboration EQRxNews Page

Turning Point Therapeutics and EQRx Announce Clinical Collaboration

Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…

Arboretum_JDOctober 14, 2021

Akadeum Life Sciences, Inc. Raises $17.5M Financing Round Led by Arboretum Ventures AkadeumHome PageNews Page

Akadeum Life Sciences, Inc. Raises $17.5M Financing Round Led by Arboretum Ventures

Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B…

Arboretum_JDOctober 12, 2021

Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System DelphinusHome PageNews Page

Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System

Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has…

Arboretum_JDOctober 12, 2021

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression Koya MedicalNews Page

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient…

Arboretum_JDOctober 11, 2021

EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs EQRxNews Page

EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

Arboretum_JDOctober 7, 2021

Jan Garfinkle Discusses Her Path to Success & Words of Wisdom Acquired During An Impressive Career ArboretumNews Page

Jan Garfinkle Discusses Her Path to Success & Words of Wisdom Acquired During An Impressive Career

Jan joins Andrew Cleeland, CEO of Fogarty Innovation and shares insights behind her successful career.

Arboretum_JDOctober 7, 2021

Koya Medical Receives FDA Clearance for Dayspring Lite Koya MedicalNews Page

Koya Medical Receives FDA Clearance for Dayspring Lite

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…

Arboretum_JDSeptember 29, 2021